Clinical Trial Update: Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, and pharmacodynamics of Ionis-DGAT2Rx in adults with hepatic steatosis (type 2 diabetes context). Completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis

Drugs mentioned

• IONIS-DGAT2Rx (DGAT2 antisense oligonucleotide)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Hepatic Steatosis | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27